{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:20:48Z","timestamp":1783102848737,"version":"3.54.6"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010393","name":"School of Dentistry, University of Maryland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201800043C"],"award-info":[{"award-number":["HHSN272201800043C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHS-NIH-NIAID-BAA2017"],"award-info":[{"award-number":["HHS-NIH-NIAID-BAA2017"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.vaccine.2026.128774","type":"journal-article","created":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T17:39:11Z","timestamp":1780249151000},"page":"128774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["BECC-adjuvanted hemagglutinin influenza vaccine promotes enhanced immunogenicity and protective efficacy"],"prefix":"10.1016","volume":"87","author":[{"given":"Sayan","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon M.","family":"Tenaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Speed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Baracco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca M.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Varisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyojik","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haye","family":"Nijhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Kerstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Frieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2026.128774_bb0005","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3390\/vaccines11081391","article-title":"Advances in adjuvanted influenza vaccines","volume":"11","author":"Shichinohe","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128774_bb0010","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s12276-021-00603-0","article-title":"The evolution and future of influenza pandemic preparedness","volume":"53","author":"Harrington","year":"2021","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.vaccine.2026.128774_bb0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128774_bb0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/irv.12871","article-title":"Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysis","volume":"15","author":"Coleman","year":"2021","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2026.128774_bb0025","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128774_bb0030","first-page":"352","article-title":"An overview of vaccine adjuvants: current evidence and future perspectives","volume":"10","author":"Facciola","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128774_bb0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/21645515.2017.1415684","article-title":"Adjuvanted influenza vaccines","volume":"14","author":"Tregoning","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128774_bb0040","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2021.06.085","article-title":"Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection","volume":"39","author":"Haupt","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128774_bb0045","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/CVI.00156-06","article-title":"Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza","volume":"13","author":"Huber","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2026.128774_bb0050","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.4049\/jimmunol.1102696","article-title":"The importance of adjuvant formulation in the development of a tuberculosis vaccine","volume":"188","author":"Baldwin","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.128774_bb0055","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1016\/j.vaccine.2009.09.066","article-title":"Optimized subunit vaccine protects against experimental leishmaniasis","volume":"27","author":"Bertholet","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128774_bb0060","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41598-023-27965-x","article-title":"Enhancing the protection of influenza virus vaccines with BECC TLR4 adjuvant in aged mice","volume":"13","author":"Haupt","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.128774_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.706157","article-title":"Effect of two unique nanoparticle formulations on the efficacy of a broadly protective vaccine against Pseudomonas aeruginosa","volume":"12","author":"Howlader","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.vaccine.2026.128774_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1194912","article-title":"Impact of the TLR4 agonist BECC438 on a novel vaccine formulation against Shigella spp","volume":"14","author":"Lu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128774_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1208848","article-title":"Immunogenicity and protective efficacy of nanoparticle formulations of L-SseB against Salmonella infection","volume":"14","author":"Das","year":"2023","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128774_bb0080","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3390\/vaccines10050714","article-title":"Influenza viruses and vaccines: the role of vaccine effectiveness studies for evaluation of the benefits of influenza vaccines","volume":"10","author":"Trombetta","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.128774_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126408","article-title":"Advancing influenza vaccines: a review of next-generation candidates and their potential for global health impact","volume":"42","author":"Taaffe","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128774_bb0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128774_bb0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41541-018-0089-x","article-title":"Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want","volume":"3","author":"HogenEsch","year":"2018","journal-title":"NPJ Vacc"},{"key":"10.1016\/j.vaccine.2026.128774_bb0100","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1586\/14760584.2013.811178","article-title":"Clinical vaccine development for H5N1 influenza","volume":"12","author":"Clegg","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2026.128774_bb0105","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1016\/j.vaccine.2016.04.002","article-title":"A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant","volume":"34","author":"Falloon","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128774_bb0110","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.vaccine.2016.04.012","article-title":"Identification of GLA\/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits","volume":"34","author":"Heeke","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128774_bb0115","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/eji.201141855","article-title":"A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo","volume":"42","author":"Pantel","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2026.128774_bb0120","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00492-17","article-title":"Rationally designed TLR4 ligands for vaccine adjuvant discovery","volume":"8","author":"Gregg","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2026.128774_bb0125","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1016\/j.vaccine.2018.05.101","article-title":"A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model","volume":"36","author":"Gregg","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128774_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126577","article-title":"Immune profile diversity is achieved with synthetic TLR4 agonists combined with the RG1-VLP vaccine in mice","volume":"44","author":"Matthews","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128774_bb0135","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1016\/j.vaccine.2023.06.080","article-title":"Intranasal VLP-RBD vaccine adjuvanted with BECC470 confers immunity against Delta SARS-CoV-2 challenge in K18-hACE2-mice","volume":"41","author":"Lee","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128774_bb0140","doi-asserted-by":"crossref","first-page":"E3216","DOI":"10.1073\/pnas.1312348110","article-title":"T-box transcription factor T-bet, a key player in a unique type of B-cell activation essential for effective viral clearance","volume":"110","author":"Rubtsova","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.128774_bb0145","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1128\/JVI.76.1.432-435.2002","article-title":"Increased efficacy of the immunoglobulin G2a subclass in antibody-mediated protection against lactate dehydrogenase-elevating virus-induced polioencephalomyelitis revealed with switch mutants","volume":"76","author":"Markine-Goriaynoff","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2026.128774_bb0150","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.190109","article-title":"The protective and pathogenic roles of IL-17 in viral infections: friend or foe?","volume":"9","author":"Ma","year":"2019","journal-title":"Open Biol"},{"key":"10.1016\/j.vaccine.2026.128774_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005367","article-title":"IL-17A promotes pulmonary B-1a cell differentiation via induction of Blimp-1 expression during influenza virus infection","volume":"12","author":"Wang","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2026.128774_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203521","article-title":"Influenza infection directly alters innate IL-23 and IL-12p70 and subsequent IL-17A and IFN-gamma responses to pneumococcus in vitro in human monocytes","volume":"13","author":"Loughran","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2026.128774_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101725","article-title":"Viral T-cell epitopes - identification, characterization and clinical application","volume":"66","author":"Schroeder","year":"2023","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2026.128774_bb0170","doi-asserted-by":"crossref","first-page":"E5944","DOI":"10.1073\/pnas.1613225113","article-title":"Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact","volume":"113","author":"Leon","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2026.128774_bb0175","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1016\/j.celrep.2019.11.084","article-title":"Identification of antibodies targeting the H3N2 hemagglutinin receptor binding site following vaccination of humans","volume":"29","author":"Zost","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2026.128774_bb0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/imm.13019","article-title":"Basics of memory B-cell responses: lessons from and for the real world","volume":"156","author":"Wong","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2026.128774_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2021.101495","article-title":"T helper type (Th1\/Th2) responses to SARS-CoV-2 and influenza A (H1N1) virus: From cytokines produced to immune responses","volume":"70","author":"Aleebrahim-Dehkordi","year":"2022","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.vaccine.2026.128774_bb0190","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.ymthe.2022.01.011","article-title":"A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice","volume":"30","author":"Bliss","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2026.128774_bb0195","doi-asserted-by":"crossref","first-page":"21536","DOI":"10.1038\/s41598-020-78401-3","article-title":"Rapid microbial identification and colistin resistance detection via MALDI-TOF MS using a novel on-target extraction of membrane lipids","volume":"10","author":"Sorensen","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2026.128774_bb0200","doi-asserted-by":"crossref","first-page":"7460","DOI":"10.1021\/acs.analchem.1c05394","article-title":"Lipid a structural determination from a single colony","volume":"94","author":"Yang","year":"2022","journal-title":"Anal Chem"},{"key":"10.1016\/j.vaccine.2026.128774_bb0205","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/rcm.3444","article-title":"mMass data miner: an open source alternative for mass spectrometric data analysis","volume":"22","author":"Strohalm","year":"2008","journal-title":"Rapid Commun Mass Spectrom"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:51:52Z","timestamp":1783101112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"alternative-id":["S0264410X26005839"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128774","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BECC-adjuvanted hemagglutinin influenza vaccine promotes enhanced immunogenicity and protective efficacy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128774"}}